Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.81 |
| ▸ | PPARG | P37231 | 2/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 8/20 | 0.41 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655295 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL30689554 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL7057008 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL17819377 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL1132969 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL1254547 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL4445694 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL8168856 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL114922 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL1179464 | 1.00 | CYP1A2 (0.81) | CYP1A2PPARGEPHX1ALDH1A1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| EP-4362756-A1 | NUT BUTTER REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2024-05-08 | — | — | EP | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| US-20230041133-A1 | NUT BUTTER REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. | 2023-02-09 | — | — | US | claimed |
| WO-2023278756-A1 | NUT BUTTER REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2023-01-05 | — | — | WO | claimed |
| EP-2386211-B1 | USE OF RUBUSOSIDE TO REDUCE OR SUPPRESS PARTICULAR UNPLEASANT TASTE SENSATIONS | SYMRISE AG (DE) | 2016-08-10 | — | — | EP | claimed |
| WO-2013079187-A9 | TASTE-MASKING COMPOSITIONS, SWEETENER COMPOSITIONS AND CONSUMABLE PRODUCT COMPOSITIONS CONTAINING THE SAME | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2016-04-14 | — | — | WO | claimed |
| EP-2785199-A2 | TASTE-MASKING COMPOSITIONS, SWEETENER COMPOSITIONS AND CONSUMABLE PRODUCT COMPOSITIONS CONTAINING THE SAME | Nutrinova Nutrition Specialties & Food Ingredients GmbH (DE) | 2014-10-08 | — | — | EP | claimed |
| WO-2013079187-A2 | TASTE-MASKING COMPOSITIONS, SWEETENER COMPOSITIONS AND CONSUMABLE PRODUCT COMPOSITIONS CONTAINING THE SAME | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2013-06-06 | — | — | WO | claimed |
| US-20130136836-A1 | Taste-Masking Compositions, Sweetener Compositions and Consumable Product Compositions Containing the Same | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2013-05-30 | — | — | US | claimed |
| US-20130136839-A1 | Taste-Masking Compositions, Sweetener Compositions and Consumable Product Compositions Containing the Same | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2013-05-30 | — | — | US | claimed |
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| CN-1394139-A | Anticancer agents | SODA AROMATIC (JP) | 2003-01-29 | — | — | CN | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | disclosed |
| EP-4561826-A1 | METHOD FOR RECYCLING A MULTILAYER SYSTEM | Bostik SA (FR) | 2025-06-04 | — | — | EP | disclosed |
| EP-0548774-A1 | Process for producing a lactone or an ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-06-30 | — | — | EP | disclosed |
| WO-1986004897-A1 | IMPROVEMENTS IN OR RELATING TO PHEROMONES | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | CYP1A2 640/4885PPARG 192/4885EPHX1 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.